NOTTINGHAM medical firm, Olberon Ltd, has secured a five-figure loan to help manage the disruption caused by the coronavirus.
The finance was provided by First Enterprise – Enterprise Loans through the Midlands Engine Investment Fund, supported by the Coronavirus Business Interruption Loan Scheme (CBILS).
Olberon was founded in 2005 by radiologist Dr Arash Bakhtyari and develops specialist medical devices that improve intravenous accessibility and help with ear and nose procedures.
The £80,000 investment will help to alleviate operational cash-flow for the next 12 months as well as support distributors, maintain IP rights for products, and cover various legal and regulatory costs.
Olberon Ltd has developed medical devices including the Vacuderm™, a single-use tourniquet, which helps inflate the vein in cases where access is difficult, together with a children’s version Vacuderm™ for Kids and the Otorhinoscope™, a two-in-one device for examining both the ear and nose.
Other innovative products in advanced stages of development include a new pull-through tourniquet, a novel safety phlebotomy holder, a self-retracting cannula and a vibrating biopsy needle.
Dr Arash Bakhtyari, founder of Olberon Ltd, said:
“Like most businesses, we’ve had to adapt our strategies to protect ourselves through the COVID-19 pandemic and ensure the development of our unique product portfolio continues to advance within the resources available to us. All our products are unique with substantial global market opportunity, which has attracted interest in licensing and commercial collaboration.
“Thanks to the funding from First Enterprise – Enterprise Loans, we have been able to cope with the significant challenges posed over the last few months and move forwards to build on the promising start we had to the year. In the coming months, we’ll be speaking with a number of countries about the manufacture and distribution of our unique products to ensure we have a robust pipeline of work.”
Lewis Stringer, senior manager at the British Business Bank, added:
“Finance from the MEIF and CBILS can help businesses to deal with the challenges arising due to the coronavirus pandemic. The funding can be used to support cash flow and help ensure businesses remain viable. We’re pleased to see this funding support another innovative business in the East and South-East Midlands.”
The Coronavirus Business Interruption Loan Scheme (CBILS) is managed by the British Business Bank on behalf of, and with the financial backing of the Secretary of State for Business, Energy and Industrial Strategy (BEIS).
The Midlands Engine Investment Fund project is supported financially by the European Union using funding from the European Regional Development Fund (ERDF) as part of the European Structural and Investment Funds Growth Programme 2014-2020 and the European Investment Bank.
For more information on First Enterprise – Enterprise Loans visit www.first-enterprise.co.uk or follow @1st_Enterprise on Twitter.
For further information on CBILS please visit https://www.british-business-bank.co.uk/ourpartners/coronavirus-business-interruption-loan-scheme-cbils-2/
This article was written by Medilink Member, Olberon Ltd.
